BrainScope Company Inc. scored a big win last week when it received clearance from the Food and Drug Administration to market a new medical device that assesses traumatic brain injuries. The Ahead 300, which uses a smartphone attached to a custom sensor to record and analyze a patient’s brain after a head injury, will be the first device BrainScope will sell commercially. The Bethesda-based company, backed by Steve Case’s Revolution venture fund, plans to sell the device to U.S. hospitals and…
from http://www.bizjournals.com/baltimore/news/2016/09/29/bethesda-biotech-to-sell-concussion-detection.html?ana=RSS%26s=article_search
via http://baltimorecheckbook.tumblr.com/post/151096571597
No comments:
Post a Comment